| Literature DB >> 33704913 |
Klas Sandberg1,2, Marie Kleist1, Paul Enthoven2, Magnus Wijkman3.
Abstract
Hemodynamic responses to exercise in the acute phase after moderate to severe stroke have remained poorly investigated. The aim of this randomized controlled study, in which 52 (32 women) patients with moderate to severe stroke were randomized to three weeks of 20 minutes in-bed cycle exercise 5 days per week or to usual care, was to explore the systolic blood pressure (SBP) response to exercise and to evaluate the impact of the intervention on the resting and post-test systolic and diastolic blood pressures and heart rate, and on the systolic blood pressure response to exercise. We found that resting SBP decreased from baseline to post-intervention in both the intervention group (147.7 ± 18.1 mmHg to 125.3 ± 17.1 mmHg, P < .001) and in the control group (147.8 ± 23.7 mmHg to 131.4 ± 14.8 mmHg, P < .001) without a significant difference between the groups (interaction P = .308). However, there was a significant difference (interaction P = .010) regarding how Δ SBP (change in SBP from pre-test to post-test) changed from baseline to post-intervention. In the intervention group, Δ SBP increased from -1.0 ± 15.0 mmHg to 8.5 ± 9.4 mmHg, P = .009, whereas in the control group, Δ SBP decreased from 7.1 + 10.9 mmHg to 4.5 + 11.8 mmHg, P = .395. We conclude that patients randomized to in-bed cycle exercise seemed to normalize their blood pressure response to exercise to a larger extent than patients in the control group.Entities:
Keywords: exercise; hypertension; rehabilitation; stroke
Mesh:
Year: 2021 PMID: 33704913 PMCID: PMC8678757 DOI: 10.1111/jch.14232
Source DB: PubMed Journal: J Clin Hypertens (Greenwich) ISSN: 1524-6175 Impact factor: 3.738
Patient characteristics and hemodynamic variables at baseline
| Variables | Total group n = 52 | Intervention Group n = 23 | Control group n = 29 |
|---|---|---|---|
| Age (years) years Mean | |||
| Mean ± SD | 74.7 ± 9.3 | 72.7 ± 12.0 | 76.3 ± 6.4 |
| Range | 50–91 | 50–89 | 61−91 |
| Sex | |||
| Male, n (%) | 20 (38.5) | 8 (34.8) | 12 (41.4) |
| Diagnosis | |||
| Hypertension, n (%) | 37 (71.2) | 16 (69.6) | 21 (72.4) |
| Diabetes mellitus, n (%) | 8 (15.4) | 4 (17.4) | 4 (13.8) |
| Type of stroke | |||
| Ischemic, n (%) | 46 (88.5) | 23 (100) | 23 (79.3) |
| Hemorrhagic, n (%) | 6 (11.5) | 0 | 6 (20.7) |
| Side affected by symptoms | |||
| Right, n (%) | 27 (51.9) | 12 (52.2) | 15 (51.7) |
| Left, n (%) | 23 (44.2) | 10 (43.5) | 13 (44.8) |
| Unknown, n (%) | 2 (3.8) | 1 (4.3) | 1 (3.4) |
| NIHSS | 13.3 ± 4.3 | 13.4 ± 4.7 | 13.2 ± 4.1 |
| mRS | 4.4 ± 0.6 | 4.3 ± 0.7 | 4.6 ± 0.5 |
| Barthel Index | 12.6 ± 3.4 | 12.9 ± 3.9 | 12.5 ± 3.1 |
| 6MWT, (m) | 10.8 ± 39.0 | 18.5 ± 56.0 | 4.6 ± 14.7 |
| Stroke onset to baseline, (days) | 1.9 ± 1.7 | 1.4 ± 1.2 | 2.3 ± 1.9 |
Abbreviations: 6MWT, 6‐Minute Walk Test;mRS, modified Rankin Scale; NIHSS, National Institute of Health Stroke Scale.
Values are mean ± SD (standard deviation) or n (%).
Patient hemodynamic characteristics at baseline
| Baseline | All patients n = 52 Mean ± SD | Resting hypertension ≥ 140 mmHg n = 37 Mean ± SD | Resting normotension < 140 mmHg n = 15 Mean ± SD |
|
|---|---|---|---|---|
| Resting SBP (mmHg) | 147.8 ± 21.2 | 157.8 ± 14.5 | 123.1 ± 13.2 | NA |
| Post‐test SBP (mmHg) | 151.3 ± 21.6 | 160.1 ± 17.1 | 129.6 ± 15.4 | <.001 |
| Δ SBP (mmHg) | 3.5 ± 13.4 | 2.3 ± 14.1 | 6.5 ± 11.3 | .308 |
| Resting DBP (mmHg) | 77.4 ± 11.7 | 79.6 ± 11.4 | 71.9 ± 10.8 | .030 |
| Post‐test DBP (mmHg) | 79.1 ± 11.2 | 81.2 ± 11.2 | 73.9 ± 9.7 | .032 |
| Δ DBP (mmHg) | 1.7 ± 6.8 | 1.5 ± 7.1 | 1.9 ± 6.1 | .852 |
| Resting heart rate (bpm) | 78.7 ± 14.6 | 78.1 ± 14.8 | 80.2 ± 14.5 | .640 |
| Post‐test heart rate (bpm) | 82.1 ± 16.5 | 80.8 ± 16.1 | 85.4 ± 17.8 | .364 |
| Δ Heart rate (bpm) | 3.4 ± 10.9 | 2.7 ± 7.5 | 5.2 ± 16.9 | .456 |
| Peak exercise heart rate (bpm) | 86.0 ± 15.4 | 84.3 ± 15.2 | 90.3 ± 15.4 | .208 |
| Change in heart rate during exercise (bpm) | 7.3 ± 10.6 | 6.2 ± 7.0 | 10.1 ± 16.5 | .395 |
Values are means ± SD (standard deviation).
Abbreviations: bpm, beats per minute; SBP, systolic blood pressure; DBP, diastolic blood pressure; Δ: Post‐test variable‐Resting variable.
Changes in hemodynamic characteristics at resting and post‐test an in‐bed cycle exercise test performed at baseline and after 3 weeks (post‐intervention) in 52 patients in acute and subacute phase after a stroke, stratified according to randomization
| Variable | Intervention Group n = 23 | Control Group n = 29 |
| ||||
|---|---|---|---|---|---|---|---|
| Baseline Mean ± SD | Post‐intervention Mean ± SD |
| Baseline Mean ± SD | Post‐intervention Mean ± SD |
| ||
| Resting SBP, mmHg | 147.7 ± 18.1 | 125.3 ± 17.1 | <.001 | 147.8 ± 23.7 | 131.4 ± 14.8 | <.001 | .308 |
| Post‐test SBP, mmHg | 146.7 ± 18.7 | 133.7 ± 14.9 | <.001 | 155.0 ± 23.4 | 135.9 ± 18.0 | .014 | .348 |
| Δ SBP, mmHg | −1.0 ± 15.0 | 8.5 ± 9.4 | .009 | 7.1 ± 10.9 | 4.5 ± 11.8 | .395 | .010 |
| Resting DBP, mmHg | 77.4 ± 11.9 | 71.2 ± 8.8 | .738 | 77.5 ± 11.8 | 70.9 ± 9.8 | .047 | .886 |
| Post‐test DBP, mmHg | 80.6. ± 12.1 | 72.6 ± 10.2 | .807 | 77.8 ± 10.5 | 70.6 ± 11.4 | .367 | .835 |
| Δ DBP, mmHg | 3.3 ± 7.4 | 1.4 ± 7.5 | .343 | 0.4 ± 6.0 | −0.3 ± 6.8 | .664 | .642 |
| Resting heart rate, bpm | 77.3 ± 15.5 | 72.6 ± 10.5 | .050 | 79.8 ± 14.0 | 78.1 ± 11.9 | .120 | .480 |
| Post‐test heart rate, bpm | 82.5 ± 18.4 | 79.5 ± 10.5 | .405 | 81.8 ± 15.2 | 80.4 ± 12.5 | .657 | .721 |
| Δ Heart rate, bpm | 5.2 ± 15.4 | 6.9 ± 7.8 | .603 | 2.0 ± 5.3 | 2.3 ± 8.7 | .826 | .684 |
| Change in heart rate during exercise, bpm | 8.2 ± 14.5 | 15.6 ± 11.2 | .085 | 6.7 ± 6.2 | 7.3 ± 8.9 | .724 | .120 |
Values are means ± SD (standard deviation). P values denote pairwise comparisons between baseline and post‐intervention values within randomization strata.
Abbreviations: bpm, beats per minute; DBP, diastolic blood pressure; SBP, systolic blood pressure; Δ: Post‐test variable‐Resting variable.
FIGURE 1Changes in Resting (pre‐) and post‐test systolic blood pressure (SBP) and ΔSBP between baseline and post‐intervention by randomization groups. Upper figure: Resting SBP changes from baseline to post‐intervention. Center figure: Post exercise SBP changes from baseline to post‐intervention. Lower figure: ΔSBP changes from baseline to post‐intervention Δ = Post‐test SBP – Resting SBP.
Antihypertensive drugs used at baseline and after post‐intervention in 52 patients in the subacute phase after a stroke
| Total group n = 52 | Intervention Group n = 23 | Control Group n = 29 | |||||||
|---|---|---|---|---|---|---|---|---|---|
| Baseline | Post‐intervention |
| Baseline | Post‐intervention |
| Baseline | Post‐intervention |
| |
| β‐Blocker, n (%) | 21 (40.4) | 22 (42.3) | 1.000 | 9 (39.1) | 9 (39.1) | 1.000 | 12 (41.4) | 13 (44.8) | 1.000 |
| Calcium channel blocker, n (%) | 16 (30.8) | 15 (28.8) | 1.000 | 8 (34.8) | 7 (30.4) | 1.000 | 8 (27.6) | 8 (27.6) | 1.000 |
| Angiotensin converting enzyme inhibitor, n (%) | 6 (11.5) | 9 (17.3) | .250 | 2 (8.7) | 4 (17.4) | .500 | 4 (13.8) | 5 (17.2) | 1.000 |
| Angiotensin receptor blocker, n (%) | 16 (30.8) | 17 (32.7) | 1.000 | 7 (30.4) | 5 (21.7) | .754 | 9 (31.0) | 12 (41.4) | .453 |
| Spironolactone, n | 0 (0) | 0 (0) | NA | 0 (0) | 0 (0) | NA | 0 (0) | 0 (0) | NA |
| Diuretic, n (%) | 6 (11.5) | 8 (15.4) | .727 | 3 (13.0) | 3 (13.0) | 1.000 | 3 (13.0) | 5 (13.0) | .500 |
Values are expressed as numbers (percentages).